33.5 C
gurgaon
Wednesday, September 30, 2020

Today’s investments build upon the $1.42 billion HRSA has awarded to health centers to...

HHS Awards More than Half Billion Dollars Across the Nation to Expand COVID-19 Testing Today, the U.S. Department of Health and Human Services (HHS), through...

Alembic Pharmaceuticals receives USFDA Approval for Tadalafil Tablets USP, 2.5 mg, 5 mg, 10...

Alembic Pharmaceuticals Limited today announced that the Company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA)...

NorthWest Healthcare Properties Real Estate Investment Trust Announces March 2019 Distribution

NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (the "REIT") announced today that the Trustees of the REIT have declared a distribution of $0.06667 per unit...

PreScouter Joins Science Exchange to Offer Online Access to Technology Scouting Services

Science Exchange and PreScouter are partnering to offer online access to its scouting services, including tech landscaping, literature review, and vetting of new opportunities for scientists...

Suzlon Foundation organizes Health camps in remote villages in Rajasthan

Jaisalmer, India: Moving forward in its endeavor to take the message of good health and create a healthy rural India, Suzlon Foundation recently organized a...

Shilpa Medicare Ltd has received U.S. Food and Drug Administration approval

Jan 17, 2019 :Shilpa Medicare Ltd has received U.S. Food and Drug Administration approval for its ANDA, Imatinib Mesylate Tablets, 100 mg and 400...

First-in-class guanylate cyclase agonist

AstraZeneca today announced that its partner Ironwood Pharmaceuticals, Inc. has received marketing authorisation from the National Medical Products Administration (NMPA) for Linzess (linaclotide) in China for...

Wockhardt Receives US FDA Approval for Leukemia drug

Mumbai, January 21, 2019 Pharmaceutical and biotechnology major Wockhardt has received approval from the United States Food & Drug Administration (US FDA) for an ANDA...

PFIZER INITIATES PHASE 2B/3 CLINICAL TRIAL FOR PF-06651600

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today the initiation of a Phase 2b/3 clinical trial for its oral JAK3 inhibitor, PF-06651600, for the...

Schrödinger and SPARC Announce Collaboration to Accelerate Neurodegeneration Drug Development Program

Collaboration brings together Schrödinger’s in silico discovery capabilities with SPARC’s novel insights into CNS pathways to speed drug development MUMBAI and NEW YORK – December...

Recent Posts